nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.151	0.285	CbGbCtD
Ziprasidone—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.151	0.285	CbGbCtD
Ziprasidone—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.114	0.214	CbGbCtD
Ziprasidone—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0697	0.131	CbGbCtD
Ziprasidone—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0443	0.0835	CbGbCtD
Ziprasidone—Hypocholesterolaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0323	0.112	CcSEcCtD
Ziprasidone—HTR2A—arteriole—focal segmental glomerulosclerosis	0.0102	0.227	CbGeAlD
Ziprasidone—Swollen tongue—Cyclosporine—focal segmental glomerulosclerosis	0.00915	0.0319	CcSEcCtD
Ziprasidone—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00769	0.0268	CcSEcCtD
Ziprasidone—Paresis—Cyclosporine—focal segmental glomerulosclerosis	0.00737	0.0257	CcSEcCtD
Ziprasidone—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.00565	0.0197	CcSEcCtD
Ziprasidone—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.0165	CcSEcCtD
Ziprasidone—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00428	0.0149	CcSEcCtD
Ziprasidone—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00423	0.0148	CcSEcCtD
Ziprasidone—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00414	0.0145	CcSEcCtD
Ziprasidone—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00383	0.0134	CcSEcCtD
Ziprasidone—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00373	0.013	CcSEcCtD
Ziprasidone—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.0129	CcSEcCtD
Ziprasidone—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.0119	CcSEcCtD
Ziprasidone—HTR7—endothelium—focal segmental glomerulosclerosis	0.00336	0.0746	CbGeAlD
Ziprasidone—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.0111	CcSEcCtD
Ziprasidone—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.0108	CcSEcCtD
Ziprasidone—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.0107	CcSEcCtD
Ziprasidone—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00304	0.0106	CcSEcCtD
Ziprasidone—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.0104	CcSEcCtD
Ziprasidone—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.0104	CcSEcCtD
Ziprasidone—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.0103	CcSEcCtD
Ziprasidone—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.0103	CcSEcCtD
Ziprasidone—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.0029	0.0101	CcSEcCtD
Ziprasidone—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0029	0.0101	CcSEcCtD
Ziprasidone—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.01	CcSEcCtD
Ziprasidone—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00286	0.0635	CbGeAlD
Ziprasidone—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.00985	CcSEcCtD
Ziprasidone—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.00985	CcSEcCtD
Ziprasidone—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.00955	CcSEcCtD
Ziprasidone—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.00937	CcSEcCtD
Ziprasidone—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00264	0.00921	CcSEcCtD
Ziprasidone—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00905	CcSEcCtD
Ziprasidone—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00905	CcSEcCtD
Ziprasidone—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00885	CcSEcCtD
Ziprasidone—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.0088	CcSEcCtD
Ziprasidone—H1F0—nephron tubule—focal segmental glomerulosclerosis	0.00249	0.0554	CbGeAlD
Ziprasidone—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00245	0.0543	CbGeAlD
Ziprasidone—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.00848	CcSEcCtD
Ziprasidone—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.00848	CcSEcCtD
Ziprasidone—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.00839	CcSEcCtD
Ziprasidone—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.00818	CcSEcCtD
Ziprasidone—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.00813	CcSEcCtD
Ziprasidone—ADRA1B—kidney—focal segmental glomerulosclerosis	0.00232	0.0515	CbGeAlD
Ziprasidone—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00798	CcSEcCtD
Ziprasidone—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00782	CcSEcCtD
Ziprasidone—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00775	CcSEcCtD
Ziprasidone—H1F0—kidney—focal segmental glomerulosclerosis	0.00219	0.0487	CbGeAlD
Ziprasidone—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00757	CcSEcCtD
Ziprasidone—H1F0—cortex of kidney—focal segmental glomerulosclerosis	0.00213	0.0474	CbGeAlD
Ziprasidone—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.0074	CcSEcCtD
Ziprasidone—HTR2A—endothelium—focal segmental glomerulosclerosis	0.00209	0.0465	CbGeAlD
Ziprasidone—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00724	CcSEcCtD
Ziprasidone—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00718	CcSEcCtD
Ziprasidone—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00715	CcSEcCtD
Ziprasidone—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.00712	CcSEcCtD
Ziprasidone—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00697	CcSEcCtD
Ziprasidone—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00694	CcSEcCtD
Ziprasidone—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.0068	CcSEcCtD
Ziprasidone—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00637	CcSEcCtD
Ziprasidone—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00615	CcSEcCtD
Ziprasidone—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00613	CcSEcCtD
Ziprasidone—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00602	CcSEcCtD
Ziprasidone—HTR1D—kidney—focal segmental glomerulosclerosis	0.0017	0.0377	CbGeAlD
Ziprasidone—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00588	CcSEcCtD
Ziprasidone—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00573	CcSEcCtD
Ziprasidone—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00564	CcSEcCtD
Ziprasidone—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0055	CcSEcCtD
Ziprasidone—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00547	CcSEcCtD
Ziprasidone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00535	CcSEcCtD
Ziprasidone—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00532	CcSEcCtD
Ziprasidone—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.00531	CcSEcCtD
Ziprasidone—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00527	CcSEcCtD
Ziprasidone—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00524	CcSEcCtD
Ziprasidone—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00524	CcSEcCtD
Ziprasidone—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00515	CcSEcCtD
Ziprasidone—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00514	CcSEcCtD
Ziprasidone—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00511	CcSEcCtD
Ziprasidone—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0051	CcSEcCtD
Ziprasidone—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.005	CcSEcCtD
Ziprasidone—CHRM3—kidney—focal segmental glomerulosclerosis	0.00142	0.0315	CbGeAlD
Ziprasidone—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00495	CcSEcCtD
Ziprasidone—ADRA2C—nephron tubule—focal segmental glomerulosclerosis	0.00141	0.0314	CbGeAlD
Ziprasidone—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00473	CcSEcCtD
Ziprasidone—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00472	CcSEcCtD
Ziprasidone—HTR7—kidney—focal segmental glomerulosclerosis	0.00135	0.03	CbGeAlD
Ziprasidone—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00471	CcSEcCtD
Ziprasidone—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00471	CcSEcCtD
Ziprasidone—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00468	CcSEcCtD
Ziprasidone—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00467	CcSEcCtD
Ziprasidone—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00465	CcSEcCtD
Ziprasidone—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00463	CcSEcCtD
Ziprasidone—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00461	CcSEcCtD
Ziprasidone—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00454	CcSEcCtD
Ziprasidone—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00439	CcSEcCtD
Ziprasidone—ADRA2C—kidney—focal segmental glomerulosclerosis	0.00124	0.0276	CbGeAlD
Ziprasidone—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00427	CcSEcCtD
Ziprasidone—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00424	CcSEcCtD
Ziprasidone—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00422	CcSEcCtD
Ziprasidone—ADRA2C—cortex of kidney—focal segmental glomerulosclerosis	0.00121	0.0269	CbGeAlD
Ziprasidone—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00421	CcSEcCtD
Ziprasidone—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00416	CcSEcCtD
Ziprasidone—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00118	0.0263	CbGeAlD
Ziprasidone—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00412	CcSEcCtD
Ziprasidone—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0041	CcSEcCtD
Ziprasidone—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00404	CcSEcCtD
Ziprasidone—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00394	CcSEcCtD
Ziprasidone—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00386	CcSEcCtD
Ziprasidone—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.00384	CcSEcCtD
Ziprasidone—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00379	CcSEcCtD
Ziprasidone—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00377	CcSEcCtD
Ziprasidone—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00374	CcSEcCtD
Ziprasidone—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00368	CcSEcCtD
Ziprasidone—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00367	CcSEcCtD
Ziprasidone—CYP3A5—kidney—focal segmental glomerulosclerosis	0.00104	0.0231	CbGeAlD
Ziprasidone—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00358	CcSEcCtD
Ziprasidone—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00354	CcSEcCtD
Ziprasidone—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.00101	0.0225	CbGeAlD
Ziprasidone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00349	CcSEcCtD
Ziprasidone—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00349	CcSEcCtD
Ziprasidone—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00349	CcSEcCtD
Ziprasidone—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000997	0.00348	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000994	0.00346	CcSEcCtD
Ziprasidone—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000978	0.00341	CcSEcCtD
Ziprasidone—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000967	0.00337	CcSEcCtD
Ziprasidone—ADRA2A—cortex of kidney—focal segmental glomerulosclerosis	0.000965	0.0214	CbGeAlD
Ziprasidone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000953	0.00332	CcSEcCtD
Ziprasidone—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000941	0.00328	CcSEcCtD
Ziprasidone—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000939	0.00327	CcSEcCtD
Ziprasidone—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000932	0.00325	CcSEcCtD
Ziprasidone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000927	0.00323	CcSEcCtD
Ziprasidone—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000914	0.00319	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000874	0.00305	CcSEcCtD
Ziprasidone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000867	0.00302	CcSEcCtD
Ziprasidone—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000861	0.003	CcSEcCtD
Ziprasidone—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000855	0.00298	CcSEcCtD
Ziprasidone—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000853	0.00297	CcSEcCtD
Ziprasidone—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000844	0.00294	CcSEcCtD
Ziprasidone—HTR2A—kidney—focal segmental glomerulosclerosis	0.000843	0.0187	CbGeAlD
Ziprasidone—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000834	0.00291	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000828	0.00289	CcSEcCtD
Ziprasidone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000827	0.00288	CcSEcCtD
Ziprasidone—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00082	0.00286	CcSEcCtD
Ziprasidone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00079	0.00276	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000784	0.00273	CcSEcCtD
Ziprasidone—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00078	0.0173	CbGeAlD
Ziprasidone—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000768	0.0171	CbGeAlD
Ziprasidone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000762	0.00266	CcSEcCtD
Ziprasidone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00264	CcSEcCtD
Ziprasidone—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00264	CcSEcCtD
Ziprasidone—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000707	0.00246	CcSEcCtD
Ziprasidone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000688	0.0024	CcSEcCtD
Ziprasidone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000656	0.00229	CcSEcCtD
Ziprasidone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000634	0.00221	CcSEcCtD
Ziprasidone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00061	0.00213	CcSEcCtD
Ziprasidone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000605	0.00211	CcSEcCtD
Ziprasidone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000604	0.00211	CcSEcCtD
Ziprasidone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000601	0.0021	CcSEcCtD
Ziprasidone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00057	0.00199	CcSEcCtD
Ziprasidone—CHRM4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.88e-05	0.000282	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.88e-05	0.000281	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.84e-05	0.000279	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.82e-05	0.000277	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.8e-05	0.000276	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.78e-05	0.000274	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.77e-05	0.000274	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.76e-05	0.000273	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.76e-05	0.000273	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.75e-05	0.000272	CbGpPWpGaD
Ziprasidone—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.75e-05	0.000272	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.74e-05	0.000271	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.72e-05	0.00027	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.71e-05	0.00027	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.7e-05	0.000269	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.69e-05	0.000268	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.69e-05	0.000268	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.69e-05	0.000268	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.69e-05	0.000268	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.68e-05	0.000267	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.67e-05	0.000267	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	3.67e-05	0.000266	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.67e-05	0.000266	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.66e-05	0.000266	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.63e-05	0.000263	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.62e-05	0.000263	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.61e-05	0.000262	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.6e-05	0.000262	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.59e-05	0.000261	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.57e-05	0.000259	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.56e-05	0.000259	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.54e-05	0.000257	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	3.52e-05	0.000255	CbGpPWpGaD
Ziprasidone—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.5e-05	0.000254	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.49e-05	0.000254	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.47e-05	0.000252	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.45e-05	0.00025	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.44e-05	0.00025	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.43e-05	0.000249	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.42e-05	0.000248	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	3.42e-05	0.000248	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.41e-05	0.000248	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.41e-05	0.000248	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.41e-05	0.000247	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.4e-05	0.000247	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.39e-05	0.000246	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.39e-05	0.000246	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.39e-05	0.000246	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.38e-05	0.000246	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.38e-05	0.000245	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.37e-05	0.000245	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.36e-05	0.000244	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.36e-05	0.000244	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.33e-05	0.000242	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.32e-05	0.000241	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.32e-05	0.000241	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.26e-05	0.000237	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.25e-05	0.000236	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.22e-05	0.000234	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.21e-05	0.000233	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.15e-05	0.000229	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.15e-05	0.000229	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.15e-05	0.000229	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.15e-05	0.000229	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.13e-05	0.000227	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.1e-05	0.000225	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.1e-05	0.000225	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.09e-05	0.000224	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.09e-05	0.000224	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.08e-05	0.000224	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.08e-05	0.000223	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.06e-05	0.000222	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.06e-05	0.000222	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.05e-05	0.000221	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.04e-05	0.000221	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.04e-05	0.00022	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.03e-05	0.00022	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	3.03e-05	0.00022	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.02e-05	0.000219	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	3.01e-05	0.000219	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.98e-05	0.000216	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.96e-05	0.000215	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.95e-05	0.000214	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.95e-05	0.000214	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.94e-05	0.000214	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.94e-05	0.000214	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.94e-05	0.000213	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.94e-05	0.000213	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	2.92e-05	0.000212	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.9e-05	0.00021	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.9e-05	0.00021	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.9e-05	0.00021	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.86e-05	0.000207	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.85e-05	0.000207	CbGpPWpGaD
Ziprasidone—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.84e-05	0.000206	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.82e-05	0.000205	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.81e-05	0.000204	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.8e-05	0.000203	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.78e-05	0.000202	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	2.78e-05	0.000201	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.71e-05	0.000197	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.71e-05	0.000196	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.68e-05	0.000194	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.67e-05	0.000194	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.66e-05	0.000193	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.63e-05	0.000191	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.62e-05	0.00019	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.62e-05	0.00019	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.62e-05	0.00019	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.62e-05	0.00019	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.62e-05	0.00019	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.61e-05	0.000189	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.61e-05	0.000189	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.6e-05	0.000189	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.6e-05	0.000189	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.59e-05	0.000188	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	2.59e-05	0.000188	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.58e-05	0.000187	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.57e-05	0.000187	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.55e-05	0.000185	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.55e-05	0.000185	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.55e-05	0.000185	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	2.54e-05	0.000185	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.54e-05	0.000184	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.53e-05	0.000184	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.53e-05	0.000183	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.51e-05	0.000182	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	2.51e-05	0.000182	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.51e-05	0.000182	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.51e-05	0.000182	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.5e-05	0.000181	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.48e-05	0.00018	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.46e-05	0.000178	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.44e-05	0.000177	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.43e-05	0.000176	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.42e-05	0.000176	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.42e-05	0.000175	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.41e-05	0.000175	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.41e-05	0.000175	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.4e-05	0.000175	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.4e-05	0.000174	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.4e-05	0.000174	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.39e-05	0.000174	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	2.37e-05	0.000172	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.37e-05	0.000172	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.37e-05	0.000172	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.37e-05	0.000172	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.33e-05	0.000169	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.32e-05	0.000169	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.32e-05	0.000168	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	2.31e-05	0.000168	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.26e-05	0.000164	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.26e-05	0.000164	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.26e-05	0.000164	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	2.24e-05	0.000163	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.23e-05	0.000162	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.22e-05	0.000161	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.22e-05	0.000161	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	2.21e-05	0.00016	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.2e-05	0.00016	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.18e-05	0.000158	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.18e-05	0.000158	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	2.18e-05	0.000158	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.17e-05	0.000158	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.16e-05	0.000157	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.15e-05	0.000156	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.14e-05	0.000156	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.14e-05	0.000155	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.05e-05	0.000149	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.04e-05	0.000148	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.02e-05	0.000146	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.01e-05	0.000146	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.01e-05	0.000146	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.01e-05	0.000146	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.01e-05	0.000146	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.01e-05	0.000146	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2e-05	0.000145	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.99e-05	0.000145	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	1.99e-05	0.000144	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.99e-05	0.000144	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.98e-05	0.000144	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.97e-05	0.000143	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.95e-05	0.000142	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.94e-05	0.000141	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.94e-05	0.000141	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.93e-05	0.00014	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.92e-05	0.00014	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.9e-05	0.000138	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.88e-05	0.000136	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.85e-05	0.000134	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.83e-05	0.000133	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	1.82e-05	0.000132	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.82e-05	0.000132	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.81e-05	0.000131	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.73e-05	0.000126	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.71e-05	0.000124	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.71e-05	0.000124	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.71e-05	0.000124	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.68e-05	0.000122	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.67e-05	0.000122	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	1.67e-05	0.000121	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.67e-05	0.000121	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.66e-05	0.000121	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.66e-05	0.00012	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.65e-05	0.00012	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.65e-05	0.00012	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.64e-05	0.000119	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.64e-05	0.000119	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.61e-05	0.000117	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.58e-05	0.000115	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.57e-05	0.000114	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.56e-05	0.000113	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.55e-05	0.000112	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.54e-05	0.000112	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.53e-05	0.000111	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.53e-05	0.000111	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.5e-05	0.000109	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.49e-05	0.000108	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.48e-05	0.000107	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.44e-05	0.000105	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.43e-05	0.000104	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.42e-05	0.000103	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.41e-05	0.000102	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	1.31e-05	9.52e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.31e-05	9.48e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.29e-05	9.33e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.28e-05	9.31e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.28e-05	9.28e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.27e-05	9.25e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.27e-05	9.22e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.26e-05	9.16e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.26e-05	9.14e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.23e-05	8.9e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.22e-05	8.86e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1.19e-05	8.62e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.19e-05	8.61e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.18e-05	8.58e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.17e-05	8.49e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.17e-05	8.48e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.08e-05	7.82e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.06e-05	7.69e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.06e-05	7.67e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.05e-05	7.65e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.05e-05	7.62e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.04e-05	7.55e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.04e-05	7.53e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.01e-05	7.34e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.01e-05	7.3e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.64e-06	7e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	7.76e-06	5.64e-05	CbGpPWpGaD
